Exagen Correlations

XGN Stock

USD 2.85 0.25 9.62%

The current 90-days correlation between Exagen Inc and Unicycive Therapeutics is 0.08 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Exagen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Exagen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Exagen Correlation With Market

Average diversification

The correlation between Exagen Inc and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Exagen Inc and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Exagen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Moving together with Exagen Stock

0.65	ME	23Andme Holding	Pair Corr
0.7	VINC	Vincerx Pharma Earnings Call Tomorrow	Pair Corr

Moving against Exagen Stock

0.68	DRUG	Bright Minds Biosciences	Pair Corr
0.6	VCYT	Veracyte	Pair Corr
0.53	DMAC	DiaMedica Therapeutics Earnings Call Today	Pair Corr
0.43	VERA	Vera Therapeutics	Pair Corr
0.4	VERV	Verve Therapeutics	Pair Corr
0.4	DSGN	Design Therapeutics Earnings Call Today	Pair Corr
0.75	VSTM	Verastem Buyout Trend	Pair Corr
0.74	VRNA	Verona Pharma PLC	Pair Corr
0.57	VRDN	Viridian Therapeutics Earnings Call Today	Pair Corr
0.53	VIGL	Vigil Neuroscience	Pair Corr
0.53	VKTX	Viking Therapeutics	Pair Corr
0.45	SABSW	SAB Biotherapeutics	Pair Corr
0.42	KTTAW	Pasithea Therapeutics	Pair Corr

Related Correlations Analysis

	UNCY	HOTH	TIL
UNCY		0.39	0.3	UNCY
HOTH	0.39		0.5	HOTH
TIL	0.3	0.5		TIL
	UNCY	HOTH	TIL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Exagen Stock performing well and Exagen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Exagen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
UNCY	5.00	0.84	0.11	0.85	6.10	(6.74)	14.00	(7.32)	41.67
HOTH	5.51	1.15	0.16	(1.17)	5.09	(7.09)	11.36	(8.16)	93.34
TIL	9.12	1.73	0.31	0.55	6.39	(12.44)	20.63	(10.89)	105.83

Exagen Corporate Management

Jeffrey Black	Chief Officer	Profile
Debra Zack	Chief Officer	Profile
John Wegener	Senior Marketing	Profile
Ryan Douglas	Investors Officer	Profile
Mark Hazeltine	Chief Officer	Profile
MingChou Lee	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC